Abstract. Gene expressions and their interaction are complex and have not been definitely clarified in the placenta. To identify interactions of gene products previously not studied, we applied cDNA subtraction analyses to the placenta between days 12 and 16, days 12 and 14, days 14 and 16 of pregnancy. Among subtracted cDNAs cathepsin M, Q and R in PECs were specifically identified on days 14 and 16 pregnancy. All of these gene expressions exhibited a similar pattern to the mPL-II gene expression determined by northern blot and RT-PCR analyses. By means of in situ hybridization, these mRNAs were localized in the basal and labyrinth zones of the placenta on day 16 of pregnancy. Double staining studies of cathepsin Q or cathepsin R mRNA by in situ hybridization followed by immunohistochemical staining of mPL-II in the same section revealed that signals for cathepsin Q and cathepsin R mRNAs were colocalized in mPL-II immunopositive trophoblast cells in the basal and labyrinth zones of the placenta on day 16 of pregnancy. Possible association of cathepsins with mPL-II may play important roles in placental functions during the latter half of pregnancy in mice.
(J. Reprod. Dev. 50: [515] [516] [517] [518] [519] [520] [521] [522] [523] 2004) he placenta is a biologically specific organ in mammals. It forms an annex between the embryo and maternal endometrium and transports nutrients and oxygen from the mother to the fetus necessary for fetal growth. Generally the placenta is developed from embryonic tissue, which consists of trophoectoderm and on inner cell mass, and the maternal uterine parietal cells [1] . The most important cell types in the placenta are the trophoblast lineage, which provide the main structural and functional components needed to bring the fetal and maternal blood systems into close contact. The trophoblast is formed with trophoblast giant cells attached to the decidua, spongiotrophoblast cells, glycogen cells in the basal z o n e , c y t o t r o p h o b l a s t c e l l s a n d syncytialtrophoblast cells in the labyrinth zone [2] . The basal zone has mainly such endocrine functions as secretion of many substances, whereas the function of the labyrinth zone is transportation of nutrition and wastes, and an exchange of oxygen and carbon dioxide. These gestational dependent adaptations are believed to be controlled, at least in part, through the elaboration of chemical signals by the uterus and placenta referred to as hormones/ cytokines [3] [4] [5] . Some placental signals have been coupled to the regulation of specific maternal responses, but no specific function is known for other putative signaling molecules that have been identified.
Among the large number of signals, many prolactin (PRL) family genes including placental lactogens (PL) and prolactin like proteins (PLP) increased these gene expressions in midgestation [6] . Yet the number of genes identified as day specific is various, and the mechanisms of placenta development and maintenance are still largely unknown. The members of human prolactin/ growth hormone (PRL/GH) family, hPRL, hPL and hGH, stimulate vessel formation whereas their 16-kDa N-terminal fragments are antiangiogenetic both in vivo and in vitro [7] . The 16 kDa fragment of PRL was cleaved from intact 23 kDa PRL, and cathepsin D has been demonstrated to cleave PRL to give the corresponding fragment of 16 kDa PRL [8] . This suggested that the protease and its target hormone responsible for the formation of this fragment must be located in the same compartment in vivo.
Following this hypothesis, we focused on the relationship between PL and placentally expressed cathepsins (PECs) family [9] , in order to clarify whether PL is involved in the angiogenetic effect on placental development. The mouse PECs genes, cathepsin M, P, Q, R, 1, 2, 3 and 6 are located in a tight cluster on chromosome 13 [10] . All of them are expressed only in the placenta. The restricted expressions of these genes play an essential role in extra embryonic tissu es for implant ation, placentation and nourishment of the embryo. In t h e p r e s e n t s t u d y , w e a t t e m p t e d a c D N A subtraction analysis to determine the PECs and other related gene expression during the latter half of pregnancy. Northern blot analysis and in situ hybridization were done to confirm the placental expression of cathepsin M, Q and R mRNA. To localize cell types expressing cathepsin M, Q and R mRNA and PL-II protein in mouse placenta, a double staining method combining in situ h y b r i d i z a t i o n f o r c a t h e p s i n m R N A a n d immunohistochemistry for mPL-II was done.
Materials and Methods

Animals and tissue preparation
The animal management and experimental procedures in this study were performed according to the guidelines for animal experimentation established at this university. ICR mice used in this study were housed under controlled temperature (22 ± 2 C) in an artificially-illuminated room (12 h light; 12 h dark). Food and water were available ad libitum. On 70 days of age or older, females were mated with males and the day the vaginal plug was found was designated as day 0 of pregnancy. Placental tissues for in situ hybridizations and immunohistochemistry were removed immediately after sacrifice, fixed in 4% paraformaldehyde at 4 C overnight and embedded in paraffin. Sections 8 µm thick were cut on a microtome and mounted on 3-aminopropyltriethoxy-silane-coated slides. The serial sections were prepared from some tissues for in situ hybridization to compare the expression sites of two different genes. For northern blot and RT-PCR analysis, placenta and decidual tissues were quickly removed and frozen immediately in liquid nitrogen and stored at -80 C until use.
RNA extraction and mRNA purification
Total RNA was extracted from placenta on days 10, 12, 14, 16 and 18 of pregnancy with on Isogen RNA extraction kit (NIPPON GENE, Tokyo, Japan). mRNA was then purified with a Poly (A) + Isolation Kit (NIPPON GENE). RNA samples were quantified by spectrophotometry at 260 nm and then separated with an Agilent 2100 Bioanalyzer (Agilent, California, U.S.A) to determine their integrity.
cDNA subtraction analysis
cDNA synthesis and subtraction analysis were performed with 500 ng of poly (A) + RNA with a cDNA subtraction kit (BD Biosciences Clontech, California, U.S.A). cDNA pools were digested with restriction endonuclease RsaI according to the manufacturer's protocol to enhance subtraction efficiency. Subtracted cDNA products from two samples were inserted into vector plasmid of TA Cloning kits (Invitrogen, California, U.S.A). After transformation, 192 clones were randomly picked up and insert cDNAs in the vector plasmids were amplified by PCR with M13-specific primers. Nucleotide sequence for insert cDNA of each clone was analyzed from both ends by a dye-terminator method in ABI 3100 sequencer (Applied Biosystems, California, U.S.A). Homology searches for the nucleotide sequence of each cDNA were performed in the NCBI nonredundant sequence database (nr) and EST database with a BLAST program.
RT-PCR analysis
First strand cDNA synthesis from 1 µg of total RNA was performed with Superscript II Reverse Transcriptase (Invitrogen) according to the protocol of the manufacturer using random hexamer primers (Invitrogen). The cDNAs were then subjected to PCR amplification at 94 C for 30 s, 55 C for 30 s, and 72 C for 1 min, for 35 cycles, with a TaKaRa Taq DNA polymerase (TAKARA BIO, Kyoto, Japan) and GeneAmp PCR system 9600 (Perkin-Elmer, Connecticut, U.S.A). The PCR products were to agarose gel electrophoresis. Nucleotide sequences of the primers for mPL-II, cathepsin M, Q, R and GAPDH and each predicted product size are shown in Table 1 .
Probe preparation
F o r n o r t h e r n b l o t a n a l y s i s a n d i n s i t u hybridization, probes to the mPL-II, cathepsin M, Q, R and GAPDH were prepared from RT-PCR products. Each cDNA was subcloned into the BamH I-EcoR I site of Bluescript pSK (-) plasmid after RT-PCR amplification. This plasmid was linearlized either with EcoR I followed by transcription with T3 RNA polymerase to generate an antisense probe, or with BamH I followed by transcription with T7 RNA polymerase to generate a sense probe, respectively. Digoxigenin-labeled RNA probes for in situ hybridization were prepared with a DIG RNA Labeling Kit (Roche Applied Science, Mannheim, Germany) according to the manufacturer's instruction.
Northern blot analysis
Northern blot analysis for mouse placental mRNA was performed with an Alkphos Direct Labelling and Detection System (Amersham Biosciences, Buckinghamshire, U.K.) according to the manufacturer's instructions. Total RNA (25 µg) was electrophoresed on a 1.5% formaldehyde agarose gel and blotted onto Hybond N + nylon membrane (Amersham Biosciences) as described previously [11] . The amount of cathepsin M, Q and R mRNAs was quantified by comparison with those of GAPDH mRNA with their density.
In situ hybridization
The protocol for in situ hybridization used in this study was based on that described previously [12] . The sections were pretreated with proteinase K (10 µ g / m l ) s o l u t i o n , 0 . 2 N -H C l a n d 0 . 1 M triethanolamine before hybridization with cathepsin M, Q and R RNA probes at 55 C overnight. After hybridization, sections were washed twice in 2 × SSC and 0.2 × SSC at 55 C for 15 min each. The hybridized probes were detected with an alkaline phosphatase conjugated anti-DIG Fab fragment (Roche Applied Science). The color reaction was developed by incubation with NBT/ BCIP. Sense DIG-labeled cRNA probes were used as negative controls.
Immunohistochemistry
Fluorescence immunohistochemistry for mPL-II was performed to co-localize cathepsin gene expression in the mouse placenta. After in situ hybridization, the same sections were washed three times in PBS. The sections were autoclaved at 115 C for 5 min in 10 mM sodium citrate (pH 6), and then treated in 10% (v/v) goat normal serum plus 2% (w/v) milk powder in PBS at room temperature for 1 h. After rinsing in PBS, the sections were incubated with rabbit anti-mouse PL-II serum (1:5000 in PBS with 2% milk powder) at 4 C overnight. The sections were incubated for 1 h with cy5-conjugated goat anti-rabbit secondary antibody (1:500 in PBS with 2% milk powder). The sections were rinsed in PBS, and then mounted with Antifade Reagent (BIO RAD, California, U.S.A). A histological observation was made under a Confocal Laser Scan Microscope LSM 510 (Carl Zeiss, Oberkochen, Germany). 
Results
Screening for differentially expressed genes in placenta
To identify the differentially expressed genes in the placenta, cDNA subtraction analyses were performed between days 12 and 14, 14 and 16, and 12 and 16 of pregnancy. Subtracted cDNAs were inserted into plasmid vector, and were used to transform E. coli. A total of 192 white colonies were randomly picked up in each subtraction analysis. cDNA inserts of these colonies were checked by direct PCR and nucleotide sequence analysis. Each sequence was subjected to homology search, with a BLAST program. The results of each subtraction analysis are shown in Table 2 . Genomic, EST and minor clone were not shown. The majority of housekeeping genes, which were not differentially regulated in the stages of pregnancy examined, were not identified in those subtraction studies. The several marker genes, which were previously known to be differentially expressed, including p l a c e n t a s p e c i f i c p r o l a c t i n f a m i l y g e n e s , pregnancy-specific glycoproteins and hemoglobin, were identified in these subtraction studies. These results suggest that the cDNA subtraction analysis was effectively done in the present study.
Of the subtracted genes, the cathepsin family genes were identified in all subtraction analyses. They were called placentally expressed cathepsins (PECs), evolutionally conserved structural characteristics of this large family of cysteine proteases [9, 10] . Expression of cathepsin M, Q and R of PECs genes in comparison with mPL-II gene expression in the placenta was subsequently analyzed.
Expression of cathepsin M, Q, R and mPL-II
RT-PCR analysis was performed to determine the mPL-II gene expression in the placenta. The mPL-II gene expression was faintly observed in the day 10 placenta. It was first detectable in day 12 placenta, and then increased noticeably in day 14, 16 and 18 placentae (Fig. 1) . To obtain further information on PECs gene expressions in the placenta during pregnancy, northern blot analysis for cathepsin M, Q and R mRNA was performed. Although small amounts of mRNAs were observed in days 10 and 12 placentae, these were detected more prominently in day 14, 16 and 18 placentae (Fig. 2) .
Localization of cathepsin M, Q, R and mPL-II mRNA in the placenta
Cathepsin M, Q, R and mPL-II mRNA in the mouse placenta during pregnancy were localized by means of in situ hybridization with digoxigeninlabeled riboprobes. In order to compare expression sites of each cathepsin and mPL-II genes, serial sections were used. Weak signals for cathepsin M, Q and R mRNAs were observed on day 12 of pregnancy (data not shown). On day 16, cathepsin M mRNA was observed only in the basal zone (Fig.  3D) . On the other hand, cathepsin Q mRNA was observed in the entire area of the labyrinth zone of placenta (Fig. 3E) . Cathepsin R mRNA was observed in both basal zone and labyrinth zone of placenta (Fig. 3F) . No signal was observed in any sections with a sense probe (data not shown). As compared with the localization of mPL-II mRNA of each serial section (Fig. 3 A, B, C) , the cells of cathepsin M and R mRNA in the basal zone were observed in the same region as that of PL-II mRNA. On the other hand, cathepsin Q and R mRNA in the labyrinth zone were localized in a similar region to that of PL-II mRNA but, it was not known whether these genes were expressed in the same cells. In order to confirm this result, the following double staining method was performed.
Co-localization of cathepsin Q and R mRNA and mPL-II in placental cells
To clarify cell types expressing cathepsin mRNA and mPL-II in the labyrinth zone of the placenta, we performed a double staining method combining in situ hybridization with digoxigenin labeled riboprobes for cathepsin Q and R mRNAs and fluorescence immunohistochemistry for mPL-II. Hybridization signals for cathepsin Q and R mRNA were observed in the cells immunoreactive to mPL-II antibody in the labyrinth zone of the placenta on day 16 of pregnancy (Fig. 4) .
Discussion
In the present study, we studied specific gene expression related to the mPL synthesis by using subtracted cDNA libraries. These libraries revealed up-or down-regulated transcripts, resulting in stage specific expressions of various genes. Several genes exhibited striking expression differences in placenta among day 12, day 14 and day 16 of pregnancy. Among these genes, some genes specifically identified by cDNA subtraction analysis were cathepsin family genes, PECs [9] . The first clue to indicate that the placenta contained novel cathepsins came from inhibitor labeling of cellular protease [13] . At present, 8 genes of the cathepsin family have been identified as PECs, and they are located in a tight cluster on chromosome 13 [10] . Cathepsin M, Q and R are found in mice and rats, but homologs of these genes are not found in humans or rabbits. Cathepsins belong to a family of lysosomal proteinase and comprise a large number of members in mice. They are involved in diverse biological functions including bulk protein turnover [14, 15] , protein processing [16] , antigen presentation [17] , chronic inflammation [18] , bone resorption [19] and tumour formation and metastasis [20, 21] . Tissue distribution of each member of this family differs considerably from the others [22] . Some members including cathepsin B, H and L are expressed ubiquitously whereas others such as cathepsin K, S and W are expressed only in restricted tissues and are possibly involved in some specific functions. Some cathepsins are expressed in the placenta of different species in a spatial and temporal manner [23] [24] [25] . Afonso et al. [24] examined the expression of cathepsin B, L and D in mouse trophoblast and found that all three enzymes were expressed in giant cells, but only cathepsin D was detected in spongiotrophoblast. These observations led to speculate that the roles of these cathepsins in extraembryonic tissues were involved in supporting nutrition transports and fetal growth. Nevertheless, cathepsin B and L-deficient mice were viable and fertile and appeared normal at birth, indicating that there must be alternative target tissues or functions for these cathepsins other than those found for fetal development [26] . On the other hand, other cathepsins in PECs may play important roles in the maintenance of pregnancy or fetal development. Cathepsin 6 and cathepsin J/P are the only placenta specific cathepsins so far characterized. The cathepsin 6 transcript was first detectable in P14 placenta, and then increased towards P18. A weak but distinct positive signal for cathepsin J/P was observed in P10 and P12 placentae. The expression of cathepsin J/P was dramatically induced in P14 placenta. These are expressed specifically in labyrinthine trophoblast cells [27] .
In a recent study, it was reported that the hPRL, hGH, hPL and hGH variants had an angiogenic function in vascular formation whereas their respective 16-kDa N-terminal fragments had an opposite effect, an antiangiogenic function. In man, the N-terminal 16 kDa PL fragment derived from recombinant DNA had inhibitory actions on angiogenesis equivalent to that of 16 kDa PRL in both in vivo and in vitro experiments [7] . The 16 kDa fragment of PRL was cleaved from intact 23 kDa PRL, and cathepsin D has been shown to cleave PRL to give the corresponding fragment of 16 kDa PRL [8] . This suggested that the protease and its target hormone responsible for the formation of this fragment must be located in the same compartment in vivo. In this hypothesis, we speculated that cathepsin M, Q and R would cleave intact mPL-II similar to cathepsin D on PRL. When remodeling of the maternal uterine vasculature and growth of fetal vessels into the placenta take place after implantation, angiogenesis is essential for the development of the placenta. Placental hormones of the PRL/ GH family appear to play a role in the regulation of reorganization and growth of maternal and fetal blood vessels in placenta [5, 28] . Therefore, it is suggested that 16 kDa PL was cleaved from the 23 kDa form by PECs and affected the placental vascular formation.
The present study shown that cathepsin Q and R m R N A s w e r e c o -l o c a l i z e d i n m P L -I I immunoreactive cells in the labyrinth zone of the placenta. As mouse PL-II was secreted from the trophoblast cells in the labyrinth zone and the giant trophoblast cells in the junctional zone of the placenta [5] , these cathepsin producing cells in the labyrinth zone appeared to be trophoblast cells. Otherwise, the labyrinthine layer of the mouse placenta is known to be a major place for the exchange of gas and nutrients between maternal and fetal blood. Cathepsin Q and R may be involved in the coordination of these processes, immunological modification and/or the processing of secretory protein factors. Since there is no information about which cell type(s) expresses these cathepsins, this is the first report that clearly shows PECs gene expression by trophoblast cells in the basal and labyrinth zone. Nevertheless, it is necessary to examine the involvement of PECs in the physiological significance of the cleaved molecule in placenta in a future study.
